These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11676497)

  • 1. Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.
    Mauro L; Salerno M; Panno ML; Bellizzi D; Sisci D; Miglietta A; Surmacz E; Andò S
    Biochem Biophys Res Commun; 2001 Nov; 288(3):685-9. PubMed ID: 11676497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IRS-1 signaling in insulin-induced modulation of estrogen receptors in breast cancer cells.
    Andò S; Panno ML; Salerno M; Sisci D; Mauro L; Lanzino M; Surmacz E
    Biochem Biophys Res Commun; 1998 Dec; 253(2):315-9. PubMed ID: 9878535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells.
    Cesarone G; Garofalo C; Abrams MT; Igoucheva O; Alexeev V; Yoon K; Surmacz E; Wickstrom E
    J Cell Biochem; 2006 May; 98(2):440-50. PubMed ID: 16440325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.
    Morelli C; Garofalo C; Bartucci M; Surmacz E
    Oncogene; 2003 Jun; 22(26):4007-16. PubMed ID: 12821935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of estradiol on insulin signaling in the rat heart.
    Koricanac G; Milosavljevic T; Stojiljkovic M; Zakula Z; Tepavcevic S; Ribarac-Stepic N; Isenovic ER
    Cell Biochem Funct; 2009 Mar; 27(2):102-10. PubMed ID: 19226537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
    Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
    Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
    J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.
    Dromard M; Bompard G; Glondu-Lassis M; Puech C; Chalbos D; Freiss G
    Cancer Res; 2007 Jul; 67(14):6806-13. PubMed ID: 17638892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters.
    Morelli C; Garofalo C; Sisci D; del Rincon S; Cascio S; Tu X; Vecchione A; Sauter ER; Miller WH; Surmacz E
    Oncogene; 2004 Sep; 23(45):7517-26. PubMed ID: 15318176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.
    Chang Q; Li Y; White MF; Fletcher JA; Xiao S
    Cancer Res; 2002 Nov; 62(21):6035-8. PubMed ID: 12414625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
    Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
    Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
    Di Paolo S; Teutonico A; Leogrande D; Capobianco C; Schena PF
    J Am Soc Nephrol; 2006 Aug; 17(8):2236-44. PubMed ID: 16807405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
    Sharfi H; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
    de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
    J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.
    Hers I; Tavaré JM
    Biochem J; 2005 Jun; 388(Pt 2):713-20. PubMed ID: 15713122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.